On average, a life is lost every hour of the day due to lack of organ transplants.
Drug development takes too long (10 years), costs too much ($2B), and targets symptoms rather than diseases.
Animal studies are ineffective for human drug & cosmetic development and leads to the death of millions of innocent animals.
At BICO, we aim to reduce the world's organ shortage and speed up drug development.
At BICO, we aim to reduce the organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology, fundamentally shifting the global healthcare industry.
Using a combination of robotics, artificial intelligence, advanced genomics, and 3D bioprinting, our innovative technologies enable researchers and practitioners in the life sciences to conduct cell line development, perform high-throughput drug screening and diagnostics, and print human tissue models for the medical, pharmaceutical, and cosmetic industries.
Net sales April-June 20230 MSEK
Organic growth April-June 20230 %
Instruments in the field0 +
In vitro human tissue models that reduce testing costs and animal testing in the cosmetics, chemical, pharmaceutical and household industries.
Accelerating development and manufacturing of diagnostic and bioanalysis test platforms.
Providing user-friendly instruments to bring efficiency and speed to multiple application areas.